Abstract
In this study, our purpose is to evaluate cochlear and vestibular function in juveniles with IgA vasculitis using audiometry, distortion product otoacoustic emissions, and cervical vestibular evoked myogenic potential (cVEMP) tests. Forty children diagnosed with IgA vasculitis from the pediatry clinic and 40 age- and sex-matched healthy children were evaluated with distortion product otoacoustic emissions, audiometry, and cVEMP test in a tertiary hospital. The audiometry average values for both ears of the IgA vasculitis group and the control subjects were compared, and as a result, median 4.7-dB sensorineural hearing loss (SHL) was found for the IgA vasculitis group compared to the control group at 250 Hz and it was statistically significant (p < 0.001). An average of 6.4-dB SHL was detected at 8000 Hz (p < 0.001). There was a statistically significant difference among IgA vasculitis and control groups regarding measurement results of average p1-n1 latency time of both ears (0.9 ms (ms) increase, p = 0.035). In IgA vasculitis patients, the median amplitude difference of both ears’ average p1 n1 was found to be 5.6 mV, statistically significantly decreased compared to the control group (p = 0.003).
Conclusion: This study, firstly in literature, demonstrated that IgA vasculitis may have association with hearing loss and vestibular dysfunction in children. We think this might be due to autoimmune mechanisms.
What is Known: • Ig A vasculitis is a leukocytoclastic vasculitis with unknown etiology, involving the skin, joints, gastrointestinal system, kidneys, and rarely other organs. • No study has been reported for the cochlear and vestibular association of Ig A vasculitis in current literature. | |
What is New: • This study demonstrated that Ig A vasculitis may have association with hearing loss in children. • This study also demonstrated that Ig A vasculitis may have association with vestibular dysfunction in children. |
Similar content being viewed by others
Availability of data and material
Available.
Code availability
SPSS version 15.0 program.
Abbreviations
- cVEMP:
-
Cervical vestibular evoked myogenic potential
- dB:
-
Decibel
- dBnHL:
-
Decibels in hearing level
- DPOAEs:
-
Distortion product otoacoustic emissions
- HSV:
-
Henoch-Schönlein vasculitis
- ms:
-
Millisecond
- PTA:
-
Pure-tone average
- SCM:
-
Sternocleidomastoid muscle
- SHL:
-
Sensorineural hearing loss
- SNR:
-
Signal to noise ratio
References
Maritati F, Canzian A, Fenaroli P, Vaglio A (2020) Adult-onset IgA vasculitis (Henoch-Schönlein): update on therapy. Presse medicale (Paris, France : 1983) 49(3)104035. Advance online publication. https://doi.org/10.1016/j.lpm.2020.104035
Piram M, Mahr A (2013) Epidemiology of immunoglobulin A vasculitis (Henoch-Schönlein): current state of knowledge. Curr Opin Rheumatol 25(2):171–178. https://doi.org/10.1097/BOR.0b013e32835d8e2a
Iannetti L, Zito R, Bruschi S, Papetti L, Ulgiati F, Nicita F, Del Balzo F, Spalice A (2012) Recent understanding on diagnosis and management of central nervous system vasculitis in children. Clin Dev Immunol 2012:698327. https://doi.org/10.1155/2012/698327
Bagga A, Dillon MJ (2001) Leukocytoclastic vasculitis. In: Cassidy JT, Petty RE, eds. Textbook of pediatric rheumatology, W.B. Saunders, Philadelphia: pp 569–579
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitis. Arthritis Rheum 65:1–11
Yang YH, Hung CF, Hsu CR, Wang LC, Chuang YH, Lin YT, Chiang BL (2005) A nationwide survey on epidemiological characteristics of childhood Henoch-Schönlein purpura in Taiwan. Rheumatology (Oxford) 44(5):618–622
Grasland A, Pouchot J, Hachulla E, Blétry O, Papo T, Vinceneux P, & Study Group for Cogan’s Syndrome (2004) Typical and atypical Cogan’s syndrome: 32 cases and review of the literature. Rheumatology (Oxford) 43(8):1007–1015. https://doi.org/10.1093/rheumatology/keh228
Bucak A, Ulu S, Bukulmez A et al (2014) Inner ear ınvolvement in children with familial mediterranean fever. J Int Adv Otol 10:124–127. https://doi.org/10.5152/iao.2014.34
Sundel R, Szer I (2002) Vasculitis in childhood. Rheum Dis Clin North Am 28(3):625–654. https://doi.org/10.1016/s0889-857x(02)00008-x
O’Donoghue DJ, Jewkes F, Postlethwaite RJ, Ballardie FW (1992) Autoimmunity to glomerular antigens in Henoch-Schoenlein nephritis. Clinical science (London, England : 1979) 83(3)281–287. https://doi.org/10.1042/cs0830281
Miller ML (2004) Vasculitis syndromes. Nelson textbook of pediatrics 826-828
Dedeoglu F, Sundel RP (2005) Vasculitis in children. Pediatr Clin North Am 52(2):547–vii. https://doi.org/10.1016/j.pcl.2005.01.006
Leung A, Barankin B, Leong KF (2020) Henoch-Schönlein purpura in children: an updated review. Curr Pediatr Rev 16(4):265–276. https://doi.org/10.2174/1573396316666200508104708
Kim GB, Yu JJ, Yoon KL, Jeong SI, Song YH, Han JW, Hong YM, Joo CU (2017) Medium- or higher-dose acetylsalicylic acid for acute Kawasaki disease and patient outcomes. J Pediatr 184:125-129.e1. https://doi.org/10.1016/j.jpeds.2016.12.019
Scherer EQ, Yang J, Canis M et al (2010) Tumor necrosis factor-α enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling. Stroke 41(11):2618–2624. https://doi.org/10.1161/STROKEAHA.110.593327
Ichimiya I, Yoshida K, Hirano T, Suzuki M, Mogi G (2000) Significance of spiral ligament fibrocytes with cochlear inflammation. Int J Pediatr Otorhinolaryngol 56(1):45–51. https://doi.org/10.1016/s0165-5876(00)00408-0
Ak E, Harputluoglu U, Oghan F, Baykal B (2004) Behçet’s disease and hearing loss. Auris Nasus Larynx 31(1):29–33. https://doi.org/10.1016/j.anl.2003.07.006
Polat K, Uysal IO, Senel S, Güler C, Durmuş K, Müderris S (2013) Evaluation of hearing in patients with familial Mediterranean fever. European archives of oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 270(11)2871–2874. https://doi.org/10.1007/s00405-013-2347-x
Rosengren SM, Welgampola MS, Colebatch JG (2010) Vestibular evoked myogenic potentials: past, present and future. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 121(5):636–651. https://doi.org/10.1016/j.clinph.2009.10.01
Author information
Authors and Affiliations
Contributions
Conceptualization: SK, AB, ABü. Data curation: ÇG, AB, SK. Formal analysis: ÇG, EY, AK. Methodology: SK, AB, AK. Project administration: SK, ABü, EY. Visualization: ÇG, AB, EY. Writing—original draft: SK, AK, EY. Writing—review and editing: SK, ÇG, ABü.
Corresponding author
Ethics declarations
Ethics approval
All procedures performed in this study were following the ethical standards of the University Ethical Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards (ethical approval registration number: 2017/11–284).
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Consent for publication
Informed consent was obtained from all individual participants included in the study.
Conflict of interest
The authors declare no competing interests.
Additional information
Communicated by Peter de Winter
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bucak, A., Bükülmez, A., Kuzu, S. et al. Cochlear and vestibular involvement in children with IgA vasculitis. Eur J Pediatr 181, 1481–1486 (2022). https://doi.org/10.1007/s00431-021-04331-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-021-04331-5